Get started
Author

Luyang Yao

Observed name: L. Yao
ORCID: 0009-0005-3917-0749
Observed ORCID: 0009-0005-3917-0749
OpenAlex ID: A5040095241
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer
2020 · Steven H. Lin, Brian P. Hobbs, et al. · Journal of Clinical Oncology · 271
Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC
2019 · Steven H. Lin, Yan Lin, et al. · Journal of Thoracic Oncology · 140
PDF
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial
2022 · Yufei Liu, Luyang Yao, et al. · Lung Cancer · 33
OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer
2018 · S. Lin, X. Lin, et al. · Journal of Thoracic Oncology · 26
PDF
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025 · Everett J. Moding, Mohammad Shahrokh Esfahani, et al. · Cancer Discovery · 20
Identification of extracellular signal-regulated kinase 3 as a new interaction partner of cyclin D3
2005 · Maoyun Sun, Yuanyan Wei, et al. · Biochemical and Biophysical Research Communications · 20
CDK11p58 protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway
2007 · Xiaojing Yun, Yihong Wu, et al. · Molecular and Cellular Biochemistry · 16
Induction of apoptosis by p110C requires mitochondrial translocation of the proapoptotic BCL‐2 family member BAD
2006 · Chen Chen, Jun Yan, et al. · FEBS Letters · 16
Enumeration and molecular characterization of circulating tumor cells enriched by microcavity array from stage III non-small cell lung cancer patients
2020 · Evan N. Cohen, Gitanjali Jayachandran, et al. · Translational Lung Cancer Research · 11
PDF
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer
2022 · Steven H Lin, Heather Y Lin, et al. · Cancer Treatment and Research Communications · 9
PDF
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer
2023 · Evan N. Cohen, Gitanjali Jayachandran, et al. · Translational Lung Cancer Research · 8
PDF
I-SABR phase II randomized study of nivolumab immunotherapy and stereotactic ablative radiotherapy in early stage NSCLC: Interim analysis adverse effects.
2020 · Joe Y. Chang, Steven H. Lin, et al. · Journal of Clinical Oncology · 8
Abstract PO-069: Circulating tumor DNA kinetics to identify genomic predictors of rapid response to chemoradiation in non-small cell lung cancer
2021 · Everett J. Moding, Yufei Liu, et al. · Clinical Cancer Research · 2
Circulating Tumor DNA Changes During Chemoradiation for Lung Cancer Predict Patient Outcomes
2019 · E.J. Moding, B.Y. Nabet, et al. · International Journal of Radiation Oncology*Biology*Physics · 2
PDF
A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction.
2020 · Everett J Moding, Mohammad Shahrokh Esfahani, et al. · Journal of Clinical Oncology · 1
Data from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025 · Everett J. Moding, Mohammad Shahrokh Esfahani, et al.
Figures S1-S8 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025 · Everett J. Moding, Mohammad Shahrokh Esfahani, et al.
Table S1-S10 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025 · Everett J. Moding, Mohammad Shahrokh Esfahani, et al.
Works count: 18
Citation count: 583
H-index: 9
I10-index: 9
Year
Topic
Type